avastin_gettyimages-94867926 Avastin got an accelerated Food and Drug Administration approval for treatment of glioblastoma, but additional research found the drug didn’t extend patients’ lives. Published 1 year ago on January 17, 2023 By P.A.J.S.S. Related Topics:
